Avalo Therapeutics, Inc. (AVTX)

NCM – Цена в реальном времени. Валюта: USD

19.55

+0.08 (0.41%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

19.16

-0.39 (-1.99%)

После закрытия: Aug 12, 2026, 4:58 PM EDT

06.08.2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

WAYNE, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced business updates and financial results for the second quarter of 2026.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

Avalo Therapeutics, Inc. (AVTX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Видео

No Data

Пресс-релизы

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Видео

No Data

Пресс-релизы

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Search stocks

Avalo Therapeutics, Inc. (AVTX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Видео

No Data

Пресс-релизы

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Видео

No Data

Пресс-релизы

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates